
Exposure of neuroblastoma cell lines to imatinib results in the upregulation of the CDK inhibitor p27KIP1 as a consequence of c-Abl inhibition
Keywords: Imatinib; Neuroblastoma; p27KIP1; c-Abl; CDK2; pRbImatinib (PubChem CID: 123596); Cycloheximide (PubChem CID: 6197); 5-bromo-2′-deoxyuridine (PubChem CID: 6035); Hoechst 33258 (PubChem CID: 16218619)CDK, cyclin-dependent kinase; c-Abl, abelson tyrosine-pr